Company Profile
Better Therapeutics Stock Price, News & Analysis
- Ticker:
- BTTX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 4, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for BTTX.
Company overview
Business overview
Better Therapeutics was a digital therapeutics company focused on behavior-change software for cardiometabolic disease. The company tried to turn prescription-grade software into a chronic-care treatment option, but its identity was always tied to the difficult economics of digital health.
Geographic Base and Sector Classification
Better Therapeutics was headquartered in the United States and listed on NASDAQ. It sat in digital health rather than classic biotechnology, with a product profile centered on software-delivered care.
Business Model Characteristics
The business depended on payer adoption, clinical validation, and the ability to show that software could meaningfully change chronic-disease outcomes. Investors watched commercialization progress, reimbursement, and platform credibility more than clinical trial binaries.
Position Within the Biotechnology Landscape
Better Therapeutics occupied a small digital-therapeutics niche within healthcare innovation. Compared with drug developers, its valuation was more sensitive to commercial traction and payer access than to FDA-drug milestones.
Future catalysts
Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle. The market is focused on what remains after the digital-therapy unwind.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Better Therapeutics (BTTX)?
Better Therapeutics (BTTX) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Better Therapeutics do?
Better Therapeutics was a digital therapeutics company focused on behavior-change software for cardiometabolic disease. The company tried to turn prescription-grade software into a chronic-care treatment option, but its identity was always tied to the difficult economics of digital health.
On which exchange is BTTX stock listed?
Better Therapeutics (BTTX) is associated with NASDAQ, United States, Biopharma.
What is Better?
Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle.
Which conditions is Better Therapeutics targeting with Better?
Better Therapeutics is associated with metabolic disease based on its company overview and current catalyst commentary.
How does Better Therapeutics describe recent progress with Better?
Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle.
What is Therapeutics?
Better Therapeutics was a digital therapeutics company focused on behavior-change software for cardiometabolic disease.
What should investors watch for with Therapeutics?
Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle.